Tuesday, 30 April 2013

NEWS : Qiagen Acquires Ingenuity genetic data processor 105 million

Qiagen Acquires Ingenuity genetic data processor 105 million :
(Reuters) - Genetic testing specialist Qiagen NV (QGEN.DE) said it bought privately held U.S. software developer Ingenuity Systems Inc for $105 million to expand further into genetic sequencing technology.
The deal, which the company expects will add to earnings per share from 2015, was announced on Monday as Qiagen cut its full-year profit outlook, citing U.S. government cutbacks that are hurting research institutions. Silicon Valley-based Ingenuity helps scientists and lab operators to structure and interpret the vast amounts of genetic data that new sequencing technology has made available. Devices pioneered by companies such as Life Technologies Corp (LIFE.O) and Illumina Inc (ILMN.O) have dramatically cut down the time and cost of sequencing human DNA. But this has created a bottleneck when it comes to the analysis and interpretation of the stream of new biological data. Qiagen, which last year bought Boston-based Intelligent Bio-Systems Inc to make inroads into the fast-developing genetic sequencing market, remains on track to launch its first sequencing device in the second half and now hopes its customers will also buy Ingenuity software to parse the data. "It's no longer enough to have a readout of all the data, you need to have database algorithms and an interpretative system," CEO Peer Schatz said in a statement.
The German company now expects adjusted earnings per share of about $1.13 for 2013, down from a previous target range of $1.16-$1.18, amid budget cuts in U.S. academic research and costs linked to integrating Ingenuity. First-quarter adjusted net income was flat at $54.7 million, slightly shy of the average analyst estimate of $55.9 million in a Reuters poll. Quarterly sales edged 2 percent higher to $303.6 million.

Monday, 29 April 2013

Next-Generation Transcriptome data and Invertebrates Vertebrates gap-

Reference-Free Population Genomics from Next-Generation Transcriptional Data and the Vertebrate–Invertebrate Gap :


  1. Abstract
  2. Author Summary
  3. Introduction
  4. Results
  5. Discussion
  6. Materials and Methods
  7. Supporting Information
  8. Acknowledgments
  9. Author Contributions
  10. References
  11. Reader Comments (0)
  12. Figures

Abstract

In animals, the population genomic literature is dominated by two taxa, namely mammals and drosophilids, in which fully sequenced, well-annotated genomes have been available for years. Data from other metazoan phyla are scarce, probably because the vast majority of living species still lack a closely related reference genome. Here we achieve de novo, reference-free population genomic analysis from wild samples in five non-model animal species, based on next-generation sequencing transcriptome data. We introduce a pipe-line for cDNA assembly, read mapping, SNP/genotype calling, and data cleaning, with specific focus on the issue of hidden paralogy detection. In two species for which a reference genome is available, similar results were obtained whether the reference was used or not, demonstrating the robustness of our de novo inferences. The population genomic profile of a hare, a turtle, an oyster, a tunicate, and a termite were found to be intermediate between those of human and Drosophila, indicating that the discordant genomic diversity patterns that have been reported between these two species do not reflect a generalized vertebrate versus invertebrate gap. The genomic average diversity was generally higher in invertebrates than in vertebrates (with the notable exception of termite), in agreement with the notion that population size tends to be larger in the former than in the latter. The non-synonymous to synonymous ratio, however, did not differ significantly between vertebrates and invertebrates, even though it was negatively correlated with genetic diversity within each of the two groups. This study opens promising perspective regarding genome-wide population analyses of non-model organisms and the influence of population size on non-synonymous versus synonymous diversity.

Author Summary

The analysis of genomic variation between individuals of a given species has so far been restricted to a small number of model organisms, such as human and fruitfly, for which a fully sequenced, well-annotated reference genome was available. Here we show that, thanks to next-generation high-throughput sequencing technologies and appropriate genotype-calling methods, de novo population genomic analysis is possible in absence of a reference genome. We characterize the genomic level of neutral and selected polymorphism in five non-model animal species, two vertebrates and three invertebrates, paying particular attention to the treatment of multi-copy genes. The analyses demonstrate the influence of population size on genetic diversity in animals, the two vertebrates (hare, turtle) and the social insect (termite) being less polymorphic than the two marine invertebrates (oyster, tunicate) in our sample. Interestingly, genomic indicators of the efficiency of natural selection, both purifying and adaptive, did not vary in a simple, predictable way across organisms. These results prove the value of a diversified sampling of species when it comes to understand the determinants of genome evolutionary dynamics.


Introduction

Population genomics, the analysis of within-species, genome-wide patterns of molecular variation, is a promising area of research, both applied and fundamental [1]. So far such studies have essentially been restricted to model organisms such as yeast [2] and Arabidopsis [3], in which a well-annotated, completely sequenced genome is available. In animals, the population genomic literature has long been dominated by drosophila and human (e.g. [4], [5]). Interestingly, these two species yielded very different patterns of genome variation. The per-site average synonymous nucleotide heterozygosity (πS), for instance, is roughly twenty times as high in Drosophila melanogaster (πS~0.02 [6]) as in Homo sapiens (πS~0.001 [7]) coding sequences. The ratio of non-synonymous to synonymous polymorphisms (πN/πS) is substantially lower, and the estimated proportion of adaptive amino-acid evolution (α) substantially higher, in D. melanogaster than in H. sapiens [8]–[12]. These distinctive patterns are interpreted as reflecting differences in effective population size (Ne) between human, a large vertebrate, and drosophila, a tiny invertebrate. A small Ne in human would explain the relatively low level of genetic diversity in this species, as well as a reduced efficacy of natural selection due to enhanced genetic drift, which would increase the probability of segregation of slightly deleterious mutations (hence the higher πN/πS), and decrease the probability of fixation of adaptive ones (hence the lower α [13], [14]).

The human-drosophila contrast, however instructive it has been for molecular evolutionary research, is a comparison between just two species, out of the millions of existing animals. It is unclear whether the same picture would have been reached if a distinct vertebrate and a distinct invertebrate species had been sampled. Population genomic statistics in D. simulans were found to be essentially similar to those of D. melanogaster [15], and the central chimpanzee (Pan troglodytes), although genetically more diverse than H. sapiens, showed genomic patterns consistent with a relatively low-Ne species [16]. These are knowledgeable corroborations, but from species very closely related to D. melanogaster or H. sapiens. A very high amount of synonymous diversity and a very low πN/πS ratio were reported in the tunicate Ciona intestinalis B [17]. This was interpreted as reflecting both a high mutation rate and large population size in this marine invertebrate species. Based on a small number of markers but many species, it was found that the average nuclear genetic diversity is higher in invertebrates than in vertebrates, and in marine than in terrestrial species [18], even though the difference is lower than expected from the neutral theory [19]. The influence of Ne was also invoked to explain the variations in non-synonymous to synonymous substitution rate between species of mammals [20], [21], and between populations of mice [22] and sunflower [23].

A recent population genomic study of the European rabbit (Oryctolagus cuniculus), however, revealed large amounts of genetic diversity, and a πN/πS ratio similar to those measured in Drosophila [24]. Although perhaps abundant, rabbits, being vertebrates, are among the 5% largest living animal species. Observing a very low πN/πS ratio in this species is somehow surprising according to the population size hypothesis, knowing that density and body mass tend to be negatively correlated across species (e.g. [25]). Still in mammals, relatively high levels of genomic polymorphism in endangered primate species were recently reported [26], again questioning the link between current abundance and population genomic patterns. It should be noted that what matters regarding molecular evolution is the long-term Ne, averaged over thousands to millions of generations. It is therefore perhaps not so surprising that the Ne effect in mammals is not correctly predicted by species conservation status, as discussed in reference [26]. At any rate, the sample of metazoan species for which population genomic data are available is still quite small, and highly biased towards mammals. Genome-wide studies of additional species from various phyla appear needed to confirm or infirm the role of Ne in animal molecular evolution, and to explore variations of within-species genomic diversity across the phylogenetic and ecological dimensions.

Next-Generation Sequencing (NGS) technologies potentially offer the opportunity to gather population genomic data in non-model organisms, in the absence of prior knowledge, at affordable cost. Genomes in animals can be large, highly repetitive and, consequently, difficult to assemble. The transcriptome appears as a valuable alternative target [26]. Transcriptomics gives access to large numbers of genes at relatively low cost, plus information about gene expression levels [27]–[29], with potential applications for SNP discovery and speciation genomics [30]–[32]. However, unlike PCR-based techniques, NGS does not return alleles or genotypes at well-defined loci, but rather large amounts of mixed, noisy, anonymous sequence reads. Extracting proper population genetic information from such data is a challenge, both conceptually and computationally. Starting from raw NGS transcriptomic data, one must assemble predicted cDNA, map reads, call single nucleotide polymorphisms (SNPs) and genotypes, and calculate population genetics statistics. Each of these steps requires appropriate methods and data-cleaning strategies to cope with paralogous gene copies, unequal expression level across genes, alternative splicing, transcription errors, sequencing errors and missing data, among other problems. Obviously, the whole task is especially difficult in the absence of a well-assembled reference genome.

Here we introduce a pipeline for de novo transcriptome-based NGS population genomics, which is applied to newly-generated data from five animal species – two vertebrates and three invertebrates. Based on samples of eight to ten individuals caught in the wild, we identify between ~4,500 and ~17,000 SNPs per species, from ~2000–3500 distinct nuclear protein-coding genes. For each species, we separate synonymous versus non-synonymous variants, and estimate the level of genetic polymorphism, the amount of divergence to a closely-related outgroup, site-frequency spectra, and adaptive evolutionary rates. We assess the robustness of these statistics to various SNP-calling and data cleaning options, and to the presence/absence of a reference genome, paying specific attention to the removal of spurious SNPs due to hidden paralogy. Then we focus on the between-species variation in the average synonymous and non-synonymous levels of within-species diversity. Our expectation is that small-Ne species should show a lower πN, a lower πS, and a higher πN/πS ratio than large-Ne species. This is because genetic drift, which is enhanced in small populations, is expected to reduce the neutral and selected levels of genomic diversity, but to increase the relative probability of slightly deleterious, non-synonymous mutations (relatively to neutral, synonymous mutations) segregating at observable frequency. Our analyses suggest that the vertebrate versus invertebrate contrast is not an obvious predictor of Ne from a molecular evolutionary viewpoint


Results

Target species

Table 1 lists the five species studied in this work. The urochordate Ciona intestinalis is a model organism for evo-devo research [33]. The existence of two cryptic species, called A and B, has recently been discovered [34], [35]. C. intestinalis A, which occupies the Pacific Ocean and the Mediterranean Sea, was taken as the focal species in this study. The flat oyster Ostrea edulis is a marine bivalve of economic interest, which lives in the Eastern Atlantic coasts. C. intestinalis and O. edulis belong to two phyla, tunicates and bivalves, in which very high levels of within-species genetic diversity have been reported [17]–[19], [36]–[38]. The Iberian hare Lepus granatensis has attracted the attention as a model taxon for phylogeographic analysis and the study of speciation and reticulate evolution [39]. Its geographic range is limited to Iberia. The European pond turtle Emys orbicularis occurs in freshwater environments in Europe [40]. Both L. granatensis and E. orbicularis are terrestrial, medium-sized vertebrates, for which a relatively low Ne can be expected. The subterranean termite Reticulitermes grassei, finally, is a eusocial termite species occurring in Spain and south-west France, feeding on wood, and causing damage to human habitations. R. grassei is a small invertebrate, by far the smallest of the five species analyzed here. However, its effective population size is presumably highly reduced by eusociality – few individuals per colony contribute to reproduction. In the rest of the article, these five species will be designated as ciona, oyster, hare, turtle and termite, respectively.


cDNA assembly, read mapping, and genotype-calling

Table 1 describes the NGS data sets generated in this analysis. Nine to ten individuals per focal species and two to eight individuals per outgroup species were analysed. An average 7.85 millions single-ended illumina reads of mean length 89 were obtained per individual. In oyster, termite, hare, and turtle, 454 analysis of one or a pool of individuals provided an additional ~500,000 reads of average length 306. Roughly 50% of the data were newly generated for this study. The other 50%, i.e., eight individuals each of ciona (B species), oyster, hare and turtle, were previously used to investigate various cDNA assembling strategies [42].

The data analysis pipeline is illustrated by Figure 1, and fully described in the Material & Methods section. Depending on the species, between 28,000 and 85,000 contigs were generated by a combination of Abyss and Cap3. Illumina reads were mapped onto the predicted cDNAs using BWA. Genotypes were called using program reads2snps, which implements the maximum likelihood framework introduced by Tsagkogeorga et al. [17], in which the per-contig error rate is estimated assuming a multinomial distribution of read counts and the Hardy-Weinberg equilibrium. When the posterior probability of the best-supported genotype (either homozygote or heterozygote) was below 0.95, the position was coded as missing data. Classical population genomic statistics were calculated based on these predicted genotypes, after various data cleaning steps, using custom-witten C++ programs. The number of contigs available for population genomic analyses – i.e., contigs which passed the coverage and ORF length filters – varied among species from 1978 to 3661. Note that the 454 reads were only used at the assembly step, not for individual
genotyping.




Paralogue filtering

In the genotype-calling procedure described above, we assume that all the reads that map to a given position correspond to a single locus. It might be, however, that reads from distinct loci map to the same place. This is expected to occur in cases of undetected paralogy, copy number variation, and repetitive genomes. In such cases, variation between paralogues might result in spurious heterozygous genotype calls. We introduced a new test to detect and clean these spurious heterozygotes. Briefly, the rationale is to compare the likelihood of a model assuming one bi-allelic locus with the likelihood of a model assuming two bi-allelic loci, both carrying the same two alleles (see Material and methods and Text S1 for details). Among the sites at which at least one heterozygous genotype was called, those for which the paralogy test was significant (p-val<0.001) were discarded. Depending on the species, between 7% (ciona) and 37% (hare) of SNPs were detected as potential paralogues.


Quality control analyses

Our major analyses involve comparison of population genetic statistics between species, and so it is important to be sure that these differences are due to real biological differences and not methodological artefacts. We first analysed the variations and impact of sequencing coverage across samples and genes. The average coverage of the analysed contigs varied from 5X to 15X across individuals and species after removal of potential PCR duplicates (Figure S1), oyster being slightly less covered, on average, than the other four species. The observed heterozygosity (i.e., the proportion of predicted heterozygous sites) was calculated for all individuals. Its relative level of variation among individuals was minimal in hare (0.0013–0.0018), and maximal in turtle (0.0003–0.0017). Importantly, this value was not correlated with the average sequencing depth in any of the five species – individuals for which large amounts of data were obtained were not more (or less) heterozygous, on average, than other individuals (Figure S1). The correlation coefficient of sequencing coverage across genes was typically above 0.9 for individuals from the same species, and declined when individuals from distinct species were compared, consistent with reference [26]. No correlation was found across species between the between-individual variance in sequencing depth and the mean or between-individual variance in heterozygosity (result not shown).

Then, in all five species, the contig containing the cox1 mitochondrial gene was identified by BLAST and individually analysed. Cox1 is a highly-expressed, haploid locus for which homozygous genotypes should be recovered if nuclear-encoded paralogs (the so-called “numt”) have been correctly filtered, and contamination between samples avoided. In turtle, ciona, oyster and termite, cox1 genealogies revealed monophyletic species, and amounts of within-species mitochondrial diversity below 1% (Figure S2). Examining the predicted SNPs, we found a single (in oyster) predicted heterozygous genotype out of the ~40,000 genotyped positions. The average proportion of heterozygous genotypes across individuals and positions in these four species was 4.10−5, i.e., very low.

In hare, the cox1 tree revealed two divergent groups of L. granatensis haplotypes, of which one was more closely related to the arctic hare Lepus timidus. This is consistent with the documented introgression of L. timidus mitochondrial DNA into northern iberian populations of L. granatensis [39], [43]. A closer examination of the cox1 contig analysed here revealed that it was a complex chimera, i.e., a concatenation of fragments from the granatensis and timidus haplotypes, which are ~10% divergent from each other. Six positions in this alignment contained unexpected heterozygous genotypes. Five of them were located close to (<30 bp away from) the boundary between a granatensis and a timidus fragment. The heterozygous genotypes correspond to low-coverage positions/individuals, which occurred when most reads from a specific individual had mapped to a distinct contig – the hare assembly included several other highly-covered contigs homologous to cox1, of length 200–460 bp. When a minimal coverage of 30X per individual, instead of 10X per individual, was required to call a genotype (our “high-coverage control”, see below), all the unexpected heterozygotes disappeared. We note that such a situation – two divergent, highly-expressed alleles coexisting in the population, with each individual carrying a single copy – is presumably very uncommon. The results of our main analyses were qualitatively unchanged when the three introgressed individuals were removed from the hare data set. To summarize, our analysis of the Cox1 gene were consistent with previous knowledge regarding mtDNA evolution in the five target species, and revealed a satisfying behaviour of our genotype-calling procedure, in its basic or high-coverage version.

Finally, we investigated the geographic patterns of genetic variation the five analysed species by plotting between-individual genetic versus geographic distance (Figure S3). A clear isolation-by-distance pattern was detected in ciona, in which the Mediterranean and Californian samples were differentiated, and in turtle, in which some population substructure associated with Pleistocene glacial refugia is detected. The relationship was much weaker in oyster, and absent in hare and termite. These patterns are essentially consistent with the phylogeographic literature in these five species [40], [44]–[47], which is typically based on fewer loci but many more individuals than the current study. The concordance between these two sources of data provides additional corroboration for our inferred SNPs and genotypes.


Estimates of πN and, especially, πS were reasonably robust to the high-coverage control, even though fewer SNPs were called with the increased coverage/quality requirement (Table 2, row B). This is because requiring a higher quality decreases not only the number of predicted SNPs, but also the number of predicted homozygous positions. The slightly lower πN/πS ratio obtained from the high-coverage control might reflect a biological effect, i.e., stronger selective constraint on highly-expressed genes [48]. High levels of robustness were also obtained with respect to our “high-quality”, “threshold-free” and “clip-ends” controls (Table S2, row F, G, H).

Importantly, results were only weakly affected when reads were mapped on existing genomic references, rather than on predicted contigs (Table 2, row C). In ciona, both πN and πS were reduced by <10% in the reference-based control. In hare, the situation was a bit worse, with πN being reduced by ~30% when reads were mapped to the rabbit transcriptome, while πS was unchanged. Note that in the case of hare, the reference is ~5% divergent from our focal species, which might bias the sample towards evolutionarily conserved genes in the reference-based control. Taken together, the reference-based controls suggest that the uncertainty in cDNA prediction [42] does not impede de novo population genomic analysis from NGS transcriptomic data.

When potentially spurious SNPs due to undetected paralogy were not filtered out, the total number of analysed SNPs increased, as could have been expected (Table 2, row D). This change did not dramatically affect πS and πN, but a lower (i.e., more negative) FIS was obtained when the paralog filter was off. Negative FIS denotes an excess of heterozygotes, as compared to the Hardy-Weinberg expectation. This is unexpected from natural population samples, in which population structure and inbreeding typically result in a deficiency, rather than an excess, of heterozygotes. The observed decrease in FIS when the paralog filter was switched off suggests that erroneous SNPs/genotypes due to mapping problems are common, and that filtering them out is necessary. The slightly negative FIS measured in our main ciona and hare analysis suggest that the filter does not entirely solve the problem.

Our results were compared to an entirely different data analysis pipeline based on samtools [49] (Table 2, row E). The two approaches yielded similar results in ciona, but in hare πS was slightly decreased, and πN/πS substantially increased, when samtools was used. The same trend was observed in oyster, termite and turtle, to various extents (Table 2). To investigate further the causes of this discrepancy, we computed site frequency spectra (SFS) from the genotypes predicted by samtools versus reads2snps (our main analysis). Figure 2 displays the folded synonymous and non-synonymous SFS in hare. As far as reads2snps predictions were concerned, the proportion of low-frequency variants was higher in non-synonymous SNPs than in synonymous SNPs, as previously reported in human [13] and drosophila [50]. This is expected under the hypothesis of a prevalent influence of purifying selection on non-synonymous mutations. Such a pattern was not observed with the samtools-predicted SNPs, in which the synonymous and non-synonymous SFS were similar to each other, and similar to the SFS expected in a neutrally evolving, panmictic, Wright-Fisher population (Figure 2, left), in which the probability of observing a SNP at a derived allele frequency of k is proportional to 1/k [51]. The inferred SFS for the other four species are displayed in Figure S4. A pattern similar to the hare was observed in turtle and termite. In ciona and oyster, the contrast between the synonymous and non-synonymous spectra was weaker.



The samtools and reads2snps genotype callers differ in two main aspects. First, reads2snps does not make use of sequence quality data, and, instead, estimates the error rate, assumed to be constant across positions in a contig, from the data. When the analysis was restricted to high-quality reads only, reads2snps-based SFS were essentially unchanged (results not shown), which does not suggest that the treatment of sequencing errors is an issue here. Secondly, reads2snps places no explicit prior on the SFS, whereas the samtools caller uses a Wright-Fisher prior (equation 20 in [52]). This could explain the difference between reads2snps-predicted and samtools-predicted SFS, and especially the higher similarity of samtools-predicted SFS, both synonymous and non-synonymous, to the Wright-Fisher expectation, as reflected in Tajima's D values that are closer to zero (Figure 2, Figure S4).

Sequences from outgroup species were added to within-species alignments. Contigs showing extreme levels of synonymous divergence between focal and outgroup species (i.e., genes that exceeded the median dS by two standard deviations or more) were considered as dubious and discarded. Outgroup inclusion resulted in a strong decrease in number of analysed contigs,and a slight reduction in estimated πN/πS ratio (Table S2, row I). This presumably reflects a more accurate prediction of ORFs when data from two distinct species are available, and/or an increased level of selective constraint on the subset of genes for which orthology search was successful.


Sampling bias and variance

We examined the robustness of our results to individual sampling. We generated random sub-samples of five to nine individuals (all combinations), and re-called SNPs and genotypes. Figure 3 shows the distribution of πS and πN across sub-samples, as a function of sub-sample size, in turtle (green) and ciona (blue). In turtle, no sampling bias was detected: the average estimated πS and πN did not vary with sub-sample size. The standard deviation across all sub-samples was 5% of the πS estimate, and 7% of the πN estimate. In ciona, no bias was detected for πS, but the estimated πN slightly declined as sub-sample size decreased. The median πN across sub-samples of five individuals was 23% lower than the estimate obtained from all ten individuals. The coefficient of variation was still relatively low for both πS (8%) and πN (12%). The hare pattern was similar to turtle, and the oyster and termite patterns similar to ciona. The reasons for a decline of πN with sub-sample size in three species are unclear. The occurrence of this pattern does not appear related to the existence of population substructure (Figure S3). At any rate, this analysis indicates that our estimates of within-species synonymous and non-synonymous diversity are reasonably robust to sampling size, and that the sampling variance is well below the reported between-species differences.


Comparative population genomics in animals

The major part of the existing population genomic literature in animals is restricted to drosophila and apes. These two groups of species show contrasting patterns of within-species genetic variation, with drosophila being ~20 times as polymorphic as humans, showing more efficient purifying selection, and higher rates adaptive evolution. Here we uncovered the population genomic profile of five new non-model species – two vertebrates and three invertebrates. These five new species appear intermediate between human and drosophila in terms of genomic diversity (Figure 4). This suggests that the typical vertebrate versus invertebrate contrast is perhaps not as sharp as suggested by the human versus drosophila comparison. So far a single species, C. intestinalis B, has been documented to be more polymorphic than drosophila ([17], right-most circle in Figure 4), and a single one, aye-aye, as less polymorphic than human (based on just two individuals [26]). Still, the vertebrate versus invertebrate divide is apparent in Figure 4, in which all the vertebrate species show a per-site synonymous heterozygosity below 1%, and a per-site non-synonymous heterozygosity below 6‰. This is also true of the turtle E. orbicularis, the single non-mammalian vertebrate included in this figure. This result appears consistent with the hypothesis that effective population size (Ne) is generally higher in invertebrates than in invertebrates. The termite pattern is also quite consistent with intuitive expectations about population size: a colony of termites is comparable to many vertebrate species in terms of mass and life-history traits. Our report in termite of a significant deficit in heterogygotes (FIS>0.1) but no population structure (Figure S3D) is indicative of high levels of inbreeding, consistent with previous analyses in subterranean termites [61]. This tends to further reduce the effective population size in this species.

Species biology and ecology, however, does not explain every aspect of our data analysis. Hare, for instance, shows a lower πS and a much higher πN/πS ratio than rabbit, even though the two species are closely related, both phylogenetically and ecologically. The difference in πN/πS between the two species is even stronger when our samtools-based hare estimates are considered – i.e., the very data analysis pipeline used in rabbit [24]. Similarly, C. intestinalis A shows evidence for a smaller population size than its sister species C. intestinalis B – πS in A is four times as low as in B, and πN/πS twice as high – even though the two taxa are morphologically and ecologically indistinguishable. Finally, an unexpectedly low, vertebrate-like πS value is reported in flat oyster, despite the abundance of these marine animals in European Atlantic coasts

Most intriguingly, no significant difference was detected between vertebrates and invertebrates regarding the πN/πS ratio, even though πS and πN/πS were found to be negatively correlated across vertebrates, and across invertebrates. This is paradoxical: if a population size effect indeed accounted for the negative slopes within vertebrates and within invertebrates, then why not across the whole data set? Several explanations can be suggested. First, it must be recalled that the data points in Figure 4 were taken from several distinct studies, based on distinct gene samples, and distinct data analysis methods. Perry et al. [26], for instance, only selected SNPs covered at 30X or more, equivalently to our “high-coverage” control, which yielded a slightly reduced πN/πS ratio in ciona and hare as compared to our main analysis. It would be good to confirm the pattern of Figure 4b using a larger number species, especially non-mammals, and a common analysis strategy. Another potential methodological issue comes from our across-loci πN/πS averaging procedure, in which mean(πN/πS) is estimated as mean(πN)/mean(πS) (see Material and Methods), which might create a downward bias of unequal magnitude among species [12].

Alternatively, the distinctive behaviour of vertebrates and invertebrates in Figure 4b might reflect a true biological difference between these two groups of species. Differences in mutation rate, hereafter noted μ, could be invoked. The πN/πS ratio is independent of μ, whereas πS is essentially proportional to μ. So if μ was generally higher in invertebrates than in vertebrates, then a higher πS would be expected in the former than in the latter, for a given πN/πS ratio. However, let us recall that what matters regarding πS is the per-generation mutation rate. Published estimates of the per-generation μ indicate that this parameter is lower, not higher, in D. melanogaster and in the nematode Caenorhabditis elegans than it is in human and mouse [62], [63]. So, even though a potential influence of μ on the pattern of Figure 4b cannot be formally ruled out, current knowledge on across-species mutation rate variations would tend to even reinforce the paradox.

Selection on synonymous positions might also be a confounding factor. The genes used in this transcriptome-based study are the most highly expressed ones, i.e., prone to selection on codon usage for translation efficiency. Selected codon usage, which is documented in Drosophila but not in human [64], leads to a reduction in πS, and therefore an increase in πN/πS, irrespective of functional constraint on amino-acids. In mammals, synonymous positions are affected by GC-biased gene conversion [65], a neutral process that mimics natural selection, and is also expected to result in a decrease in πS. Substantial selective contraints on synonymous sites for efficient splicing of mRNA and nucleosome positioning are also documented, especially in mammals [66]. However, we note that such effects should affect both the X-axis (πS) and the Y-axis (πN/πS) of Figure 4b, so that a non-neutral behaviour of synonymous sites, if any, should essentially result in a re-scaling of the axes, not a shift upward of a subset of data points.

Another potential explanation to this unexpected pattern would invoke a difference in the selective regime between vertebrates and invertebrates. For a given Ne, the πN/πS ratio is expected to increase as the distribution of selection coefficients, s, of non-synonymous deleterious mutations becomes more leptokurtic [67]. One could imagine, for instance, that metabolic and protein interaction networks are more complex in vertebrates than in invertebrates [68], [69], so that the average amino-acid position is involved in a higher number of physical interactions, reducing the proportion of effectively neutral sites in vertebrates. This is consistent with the theoretical prediction of an increased variance in the distribution of deleterious selection coefficients as mutational pleiotropy increases [70]. Between-species differences in the distribution of deleterious selection coefficients are documented, with animals (drosophila and caenorhabditis) showing a higher average effect and a lower skewness as compared to micro-organisms [71].

Finally, it might be that vertebrates and invertebrates differ in their biology in such a way that the neutral and the selected levels of diversity do not respond similarly to demographic variations in the two groups. The invertebrates of this study are high-fecundity species: very large numbers of propagules (eggs, larvae, alates) are released every generation, each with a very small probability of survival to adulthood. This life cycle results in a highly skewed distribution of offspring, in which a minority of progenitors contributes to the next generation [72]. This departure from the Wright-Fisher model distinctively affects the fate of neutral [73]–[75] and selected [76] mutations, so that πS and πN/πS might respond non-linearly. At any rate, our results revivify old questions raised at the onset of experimental population genetics [77] that have been left unsolved during the long time-lag required to be able to conduct population genomics in non-model species [78].

Concluding remarks

In this study, we showed that de novo population genomics in non-model taxa can be achieved based on transcriptome data. Our analysis demonstrates the contrast between vertebrates and invertebrates regarding πN and πS, with exceptions (termites), but detects no significant difference as far as πN/πS is concerned, questioning the hypothesis that neutral and selected levels of diversity are uniquely determined by the variations of a one-dimensional variable – i.e., Ne – across organisms. The methods developed in this study will be worth applying to additional animal species to explore further the influence of species ecology on population genomics, and the role/meaning of effective population size in molecular evolution.

Materials and Methods

Sampling and sequencing

Nine or ten individuals per focal species, and one to eight individuals per outgroup species, were sampled from three to ten localities across the species range. Details on sampling dates and locations are available from Table S1. Tissues were preserved from RNA degradation using liquid nitrogen, RNAlater buffer or Guanidinium thiocyanate-Phenol solution (Trizol and TriReagent BD ) was used for termites, hares and ciona. Silica membrane - SM kits (RNEasy, Qiagen) was used for hares and ciona. We previously developed a third RNA isolation method using combined GTPC and SM [79], used here for oysters and turtles. RNA quantity and quality (purity and degradation) was assessed using NanoDrop spectrophotometry, agarose gel electrophoresis and Agilent bioanalyzer 2100 system before external sequencing (GATC, Konstanz Germany). See Table S1 and reference [79] for additional details.

Five µg of total RNA of each sample were used to build 3′-primed, non-normalized cDNA libraries, sequenced using Hiseq2000 or Genome Analyzer II (Illumina) with 8 and 5 libraries pooled per lane, respectively. Fifty bp (termite) or 100 bp (other four species) single-end reads were produced. In hare, turtle and oyster, 25 µg of total RNA of one individual per focal species was used to build a random-primed normalized cDNA library. The latter was sequenced for half a run with GS FLX Titanium (Roche ). Low quality bases, adaptors and primers were removed using the SeqClean program (http://compbio.dfci.harvard.edu/tgi/).

Bioinformatic pipeline

Figure 1 summarizes the main data analysis strategy used in this study. For each focal species, 454 and Illumina reads were assembled in contigs – i.e., predicted cDNAs – using the Abyss and Cap3 programs [80], [81], according to method D in [42]. In this approach, 454 and Illumina reads are separately assembled then merged in a mixed assembly thanks to an additional Cap3 run. Illumina reads were mapped to the contigs using BWA [82]. For each contig, average coverage was defined as the total length of mapped reads divided by contig length. Contigs less covered than an average 2.5 X per individual were immediately discarded. Open reading frames (ORF) were predicted the program transcripts_to_best_scoring_ORFs.pl, which is part of the Trinity package (http://trinityrnaseq.sf.net, courtesy of Brian Haas). This program makes use of hexanucleotide frequencies, learnt from a first pass on the data, to annotate coding sequence boundaries.

For each position of each contig and each individual, genotypes were called using the method introduced by Tsagkogeorga et al. [17] (M1 model), specifically designed to handle transcriptome-based NGS data, and implemented in the home-made program reads2snps. Briefly, this method first estimates the error rate (assumed to be shared across positions) in the maximum likelihood framework, then calculates the posterior probability of each of the 16 possible genotypes knowing the error rate, assuming Hardy-Weinberg equilibrium. When one genotype, either homozygous or heterozygous, had a posterior probability above 0.95, it was validated. Otherwise, the genotype was coded as missing data. In contrast with “variant calling” approaches (in which a homozygote is called in case of insufficient power to detect a heterozygote), no coverage-associated bias in heterozygosity prediction is expected with this method. Positions in which no more than 10 reads were available for a specific individual were also considered as missing. Prior to SNP/genotype calling, potential PCR duplicates were removed by collapsing sets of identical reads into a single read.

Paralogous gene copies are a potential source of spurious SNPs: if two distinct genes were merged in a single contig at the assembly step, then between-copy variations might be mistaken for heterozygosity. To cope with this problem, the detected SNPs were filtered for potential paralogy thanks to a newly-developed likelihood ratio test. Briefly, for a given SNP, the probability of the observed data (read counts for A, C, G and T in every individual) was calculated under the one-locus model used for SNP calling [17], on one hand, and under a two-locus model, on the other hand. The two-locus model assumes that two paralogous loci contribute reads to this SNP, with locus 1 contributing a proportion p of the reads. The two-locus model predicts an excess of heterozygotes (assuming that every individual carries and expresses the two loci), and correlated read count asymmetry across individuals (assuming that the relative contribution p of locus 1 is constant among individuals). SNPs were validated when the two-locus model did not significantly improve the fit, as compared to the one-locus model. In this test, potential departure from the 50%/50% expectation for read counts in heterozygotes was taken into account by assuming a Dirichlet-multinomial distribution of read counts, instead of a standard multinomial. Such an overdispersion of read counts is expected in case of allele-specific expression bias [83], and because of the stochasticity of allele amplification during library preparation [84]–[85]. Details of the method and simulations are provided in Text S1. The reads2snps SNP-caller and paralogue filter can be downloaded from http://kimura.univ-montp2.fr/PopPhyl/res​ources/tools/reads2snp.tar.gz.

Outgroup sequences were added to these alignments, when available. To achieve this aim, Illumina reads from the outgroup species were assembled using Abyss and Cap3, following method B in reference [42], and ORF were predicted as above. Orthologous pairs of coding sequences from the focal and the outgroup species were identified using reciprocal best BLAST hit, a hit being considered as valid when alignment length was above 130 bp, sequence similarity above 80%, and e-value below e−50. Outgroup sequences were added to within-focal species alignments using a profile-alignment version of MACSE [86], a program dedicated to the alignment of coding sequences and the detection of frameshifts. Contigs were only retained if no frameshift was identified by MACSE, and if the predicted ORF in the focal species was longer than 100 codons.

Codon sites showing a proportion of missing data above 50% were discarded. Then focal species sequences showing a proportion of missing data above 50% were removed. Alignments made of less than 10 codon sites after cleaning were removed. For each contig, the following statistics were calculated using the Bio++ library [87]: per-site synonymous (πS) and non-synonymous (πN) diversity in focal species, heterozygote deficiency (FIS), number of synonymous (pS) and non-synonymous (pN) segregating sites in focal species, number of synonymous (dS) and non-synonymous (dN) fixed differences between focal and outgroup species, neutrality index NI = (pN/pS)/(dN/dS) [88], and neutrality index calculated after removing SNPs for which the minor allele frequency was below 0.2 (NI0.2). These statistics were computed from complete, biallelic sites only – i.e., sites showing no missing data after alignment cleaning, and no more than two distinct states. The per-individual heterozygosity (proportion of heterozygote positions) was also calculated.

For each species, statistics were averaged across contigs weighting by contig length, thus giving equal weight to every SNP. Confidence intervals around estimates were obtained by bootstrapping contigs. Averaging population genomic statistics across loci can be problematic when ratios have to be calculated. The ratio of mean(πN) to mean(πS), for instance, is a biased estimate of the mean(πN/πS) if selective constraint on non-synonymous sites and neutral diversity are correlated across genes [12]. A correction for this bias was proposed [89], which is valid only if the number of synonymous SNPs per contig is large enough. This correction is not applicable to our data set, in which a majority of contigs are relatively short, and therefore include small numbers of synonymous SNPs.

The synonymous and non-synonymous site frequency spectra (SFS, i.e., the distribution of minor allele counts across SNPs) were computed based on predicted genotypes. To cope with the variable sample size across SNPs, we applied a hypergeometric projection of the observed SFS into a subsample of n = 12 sequences [90], SNPs sampled in less than n sequences being discarded. The synonymous and non-synonymous SFS were used to calculate Tajima's D [91], and to estimate the proportion of adaptive amino acid substitutions according to the method of Eyre-Walker and Keightley [53] using the DoFE program (http://www.lifesci.sussex.ac.uk/home/Ada​m_Eyre-Walker/Website/Software) – an estimate we call αEWK. This proportion was also estimated as α0.2 = 1−NI0.2 [13]. We finally calculated the (per synonymous substitution) rate of adaptive non-synonymous substitution, ωa = α dN/dS [54].












NEWS: Hares, tortoises, and the race to unravel the genetic diversity

Hares, tortoises, and the race to unravel the genetic diversity : Sun, Apr 28th, 2013 |

If you thought the only way to solve a puzzle was by looking at a picture of its end result as you go, guess again. Using an innovative approach to the study of genetic diversity, an international research team, comprising three researchers from the Research Center in Biodiversity and Genetic Resources – CIBIO/InBIO Laboratório Associado, in Portugal, demonstrated that it is possible to unveil the mechanisms underlying genetic diversity and evolutionary change, by focusing on species that are not commonly used as model-organisms.

Iberian Hare by Pedro Moreira, 2009

In the age of genome analysis, most of the strategies put forth to tackle genetic diversity have focused on a very limited number of species, for which well-annotated reference genomes are available, as for instance, fruit flies and humans. However, in a recent study, published in the latest issue of PLOS Genetics, Gayral, Melo-Ferreira and colleagues overcome the traditional paradigms of genomic analysis and their potential limitations, and show that it is possible to explore a broad range of organisms for whom that information is still incomplete or unavailable, as is the case of hares, turtles, oysters or even termites.
In a time when full genome sequencing has become quite popular in well-developed countries, José Melo-Ferreira and colleagues suggest a strategy based in next-generation sequencing, which allows obtaining insightful and reliable data from new information that is largely unknown. In spite of the inevitable challenges it presents, this approach is very stimulating, as sustained by the researcher from CIBIO, who states that “it is almost like solving a puzzle without having access to the final picture. We have shown that, instead of attempting to reconstruct the genetic profile and evolutionary history of the individuals it is possible to efficiently attain that information, without having those data to begin with. This opens new opportunities for the study of the genomes of a wide range of species, which is likely to provide a deeper understanding of the evolutionary process”.

In addition to this extraordinary technological advancement, it is important to highlight the important contribution of this study for he understanding of biological diversity. A hypothesis that is now widely accepted by the research community suggests that population size is the most determining aspect of a species’ ability to retain beneficial genetic information and remove harmful information. For instance, it is though that the diversity and adaptive capacity of invertebrates, whose populations are exceedingly numerous, are above those observed in vertebrates, typically with lower population sizes. Nevertheless, this study reveals that this is not at all a straightforward issue. As José Melo-Ferreira explains, “… in a way, our results show that this line of reasoning is too simplistic. Actually, the utter discrepancy that until now was thought to exist between the adaptive capacity of vertebrates and invertebrates, is substantially lessened if we turn our attention to species that are usually not considered”. Hence, this study paves the way to new and promising perspectives on the study of major determinants of evolution, which bare significant implications for biodiversity research and the outline of conservation strategies.

NEWS : UCSD Study conducted more sense genome data

UCSD Study conducted more sense genome data:

LA JOLLA — The ever-faster methods of genome sequencing have caused a bit of data gridlock among researchers looking into the links between DNA sequences and disease: There's too much information to easily make sense of.

A team of UC San Diego researchers says it has found a way to better interpret the mountains of genomic data to track the associations. Their study was published April 25 in two papers in the journal PLOS Genetics.

The researchers have developed a statistical method to toss out the vast amounts of data likely to be irrelevant. Scientists can then focus more closely on the information likely to be related to diseases. By better understanding the disease process at its genetic roots, researchers hope to speed development of better therapies.

The study, led by UCSD professor Anders Dale, concerns one-letter variants in the DNA alphabet. These variants are called single-nucleotide polymorphisms, or SNPs. They can occur inside genes, or in the much larger stretch of DNA found outside genes. They can be found by scanning the entire genome to find variants associated with disease; these are called genome-wide association studies, or GWAS. The human genome contains about 3 billion letters, so a change of one letter is comparatively tiny.

Modern genomic technology has identified thousands of these SNPs. This discovery has turned on its head the common notion that a certain mutation occurs "for" a certain disease. Instead of just one mutation in a disease, there are most often many mutations.

Sometimes, people will have disease-associated SNPs but not develop the disease. That fact makes the genetic tests being sold commercially of questionable value in disease prediction. Also, genetic variations may be associated with more than one disease, a condition known as pleiotropy.

Add this all up and it means there's no obvious way to associate most of these variants with diseases in any reliable fashion. That's where the UCSD-led team says its method can make a difference.

"It's increasingly evident that highly heritable diseases and traits are influenced by a large number of genetic variants in different parts of the genome, each with small effects," said Dale, a professor in the departments of Radiology, Neurosciences and Psychiatry at the UCSD School of Medicine, in a statement on the studies. "Unfortunately, it's also increasingly evident that existing statistical methods, like genome-wide association studies that look for associations between SNPs and diseases, are severely underpowered and can't adequately incorporate all of this new, exciting and exceedingly rich data."

The study developed a shortcut to finding patterns of these SNPs that bunch up in certain diseases. The conclusion is made plain in the title of one of the papers, which stated in part, "All SNPs are not created equal."

"We hypothesize that all SNPs in a GWAS are not exchangeable, but come from pre-determinable categories with different distributions of effects," the study stated. "This implies that some categories of SNPs are enriched, i.e. are more likely to be associated with a phenotype than others."

The method also includes pleiotropic information, recognizing that diseases may share common genetic causes.

NEWS :Co-discoverer of DNA highlights the importance of knowledge for success

Co-discoverer of DNA highlights the importance of knowledge for success:


The Nobel Prize winning scientist who co-discovered the structure of DNA 60 years ago has said Ireland cannot be a success in science unless it knows as much as other nations.
Dr James Watson, 86, said the investment made in research in Ireland over the past 40 years is beginning to pay off and there are some very good scientists in the country.
He was asked about comments he made last month in San Diego, where he referred to ignorance being the curse of the Irish. Dr Watson said what he meant was that historically Irish people lacked knowledge. He said that he was not implying that Irish people were stupid.
Ireland just has to be good at technology, he said, and that takes a long time and requires a serious university system. He said it is very important to make science appealing to young people.
Dr Watson, who is now engaged in cancer research, said he is convinced genetics will not lead to the discovery of a cure for cancer, but chemistry will.
On the level of investment in cancer research, he said he does not believe that too much is being spent on it.  Dr Watson said he did not think the future of cancer research is dependent on a big burst of investment in the area. He said what is really limiting the search for a cure for cancer is ideas and intelligent people.  Dr Watson was in Dublin to unveil a new sculpture in the Botanic Gardens in Dublin marking the 60th anniversary since the discovery of the double helix structure of DNA.

NEWS: Malaria Parasite drug resistance Fingerprinting 'offers a new tool for monitoring public health threat

Malaria Parasite drug resistance Fingerprinting 'offers a new tool for monitoring public health threat :  29 April 2013


Resistance to the frontline antimalarial drug, artemisinin, can be identified and tracked by analysing the genetic fingerprint of parasite populations, a study published online today in ‘Nature Genetics’ demonstrates.
The effectiveness of this key drug is weakening, threatening hundreds of thousands of lives, and new methods of tracking resistance are vital for understanding how it could be contained.

An international team of researchers used new genetic sequencing technologies to analyse the whole genetic make-up, or genomes, of samples of the malaria-causing parasite Plasmodium falciparum. They discovered multiple strains of the parasite that seem to be rapidly expanding throughout the local parasite population in Western Cambodia, a known hotspot for drug resistance. These strains have emerged recently and are all resistant to artemisinin.

The scientists were able to characterise distinct genetic patterns, or 'fingerprints', for each of the strains, showing the approach offers a rapid and novel way to detect and track the global emergence of drug resistance. Their findings provide important insights into how resistance emerges and is maintained by certain parasite populations.

A major objective of the World Health Organization is to stop the spread of malaria parasites resistant to leading drugs. Researchers from 23 institutions across South-east Asia, Africa, the USA and the UK sequenced parasite genomes from more than 800 malaria samples from Africa and South-east Asia with the aim of investigating how the large-scale genetic monitoring of malaria could identify and track drug resistance.

"Our survey of genetic variation showed that Western Cambodian malaria parasites had a population structure that was strikingly different to those of the other countries we analysed. Different not just from countries in Africa, but also different from malaria parasite populations in neighbouring Thailand, Vietnam, and even Eastern Cambodia," says Professor Dominic Kwiatkowski, senior author of the paper from the Wellcome Trust Sanger Institute and University of Oxford.

"Initially, we thought our findings might be just an anomaly. But when we investigated further we found three distinct sub-populations of drug-resistant parasites that differ not only from the susceptible parasites but also from one another. It is as if there are different ethnic groups of artemisinin-resistant parasites inhabiting the same region."

One important benefit of this genetic approach is that, even without knowing the precise genetic causes of drug resistance, researchers are able to quickly identify resistant strains - an important step towards identifying molecular markers to enable effective worldwide surveillance.

Dr Olivo Miotto, first author of the paper from Oxford University, Mahidol University in Thailand, and the MRC Centre for Genomics and Global Health, said: "Public health authorities need rapid and efficient ways to genetically detect drug-resistant parasites in order to track their emergence and spread. Our approach allows us to identify emerging populations of artemisinin-resistant parasites, and monitor their spread and evolution in real time. This knowledge will play a key role in informing strategic health planning and malaria elimination efforts."

Western Cambodia seems to be a hotspot for the emergence of drug resistance, but it is not fully known why. Resistance to other malaria drugs, namely chloroquine and sulfadoxine/pyrimethamine, first developed in South-east Asia before spreading to Africa. This study offers new leads regarding why drug resistance arises more readily in some locations than in others, which the consortium will be pursuing.

"While we have not yet identified the precise mechanism of action or resistance to artemisinin, this research represents substantial progress in that direction. It also provides an important insight into why antimalarial drug resistance (previously to chloroquine and antifols, and now to artemisinin) arises in Western Cambodia," said Professor Nicholas White, Director of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme in Thailand.

"Artemisinin resistance is an emergency which could derail all the good work of global malaria control in recent years. We desperately need methods to track it in order to contain it, and molecular fingerprinting provides this."

In the longer term, the findings provide an important resource for exploring the underlying mechanisms of resistance. Several genetic variations were discovered in genes that are suspected to play a part in drug resistance, notably those that code transporter proteins and those implicated in DNA repair. These findings provide a rich resource for researchers investigating the molecular mechanism of drug resistance.

"This research demonstrates the value of collaborative working to survey the genetic landscape of malaria across the globe," added Dr Abdoulaye Djimdé from the Malaria Research and Training Centre, University of Science, Techniques and Technologies of Bamako, Mali and the Sanger Institute. "Continuing global genetic surveillance and investigation will help us to identify the emergence of further resistant strains and improve our understanding of how they arise and spread."

There were an estimated 219 million cases of malaria in 2010 and an estimated 660 000 deaths. The World Health Organization Global Plan for Artemisinin Resistance Containment is a call to action that outlines measures to protect the value of artemisinin-based combination therapies for Plasmodium falciparum malaria.


Image caption: A gene map of the malaria genome. Credit: Wellcome Library, London.

"There is no choice for you according to the ACMG (American College of Medical Genetics)

"There is no choice for you according to the ACMG (American College of Medical Genetics)
The American College of Medical Genetics (ACMG) has recently published recommendations for reporting incidental findings (IFs) in clinical exome and genome sequencing. These recommendations advocate actively searching for a set of specific IFs unrelated to the condition under study. For example, a two-year-old child may have his (and his parents’) exome sequenced to explore a diagnosis for intellectual disability and at the same time will be tested for a series of cancer and cardiac genetic variants. The ACMG feel it is unethical not to look for a series of incidental conditions while the genome is being interrogated, conditions that the patient or their family may be able to take steps to prevent. This flies in the face of multiple international guidelines that advise against testing children for adult onset conditions. The ACMG justify this as “a fiduciary duty to prevent harm by warning patients and their families.” They conclude that “this principle supersedes concerns about autonomy,” i.e. the duty of the clinician to perform opportunistic screening outweighs the patients right not to know about other genetic conditions and their right to be able to make autonomous decisions about testing. Family have exome sequencing to determine son’s diagnosis

There is strength in the above argument if opportunistic genetic screening did indeed reveal an established predisposition to a treatable and preventable condition where steps could be taken to protect the individual or their family. But this isn’t the case with some of the conditions the ACMG insist on testing for. There are many apparently ‘disease causing’ variants that appear in healthy people with no evidence of disease, and in the absence of a strong family history it will be difficult to interpret some results. It is not too far fetched to imagine that, in the hands of a health professional who doesn’t understand the limitations of the testing, that a supposed BRCA1 gene fault will be identified in a women who is then advised to have preventative surgery to remove her ovaries and breasts. And yet in the absence of a family history, it is impossible to tell whether the BRCA1 gene fault is fully penetrant and whether there are any modifying genes at play.

The ACMG acknowledge “there are insufficient data on clinical utility to fully support these recommendations… and… insufficient evidence about benefits, risks and costs of disclosing incidental findings to make evidence-based recommendations”. Yet, they clearly felt the need to draw a line in the sand and create a starting point. This is a bold and fearless move. The result is that a set of conditions, genes and variants are listed, many of which will reveal uncertain pathogenicity in the absence of a family history. Moreover, in many cases, there is no screening program available (what should be offered to a child with a P53 mutation? There is no universal agreement on whether screening for rhabdomyosarcoma is appropriate). The intent was to identify “disorders where preventative measures and/or treatments were available” but the reality falls short somewhat.

Finally, the ACMG “Working Group encourages prospective research on incidental or secondary findings and the development of a voluntary national patient registry to longitudinally follow individuals and their families who receive incidental or secondary findings as part of clinical sequencing and document the benefits, harms and costs that may result.” In effect, what they are saying is that we don’t really know what the impact of this technology will be, and only time will tell whether our risk predictions are correct. Given such uncertainty and also the fact that many of the families and individuals who will be accessing this technology are incredibly vulnerable (by virtue of their desperate need for a diagnosis for example, for a developmental disorder), it strikes us that this all should actually be part of a research project and not offered as a clinical service. Under the guise of ‘research’ this makes much more sense. What do you think? If you want to contribute to other discussions about ethics and genomics, see our survey.

Consider the ACMG guidelines with the following fictitious case study in mind….

CASE STUDY

Bobby is a severely disabled six-year-old. He has a learning disability and hyperactivity, and is incontinent.  Numerous paediatricians have seen the family over many years, but existing tests haven’t led to a diagnosis. Bobby’s parents are anxious to have a name for his condition. Without an actual diagnosis it is more challenging to access the educational and respite care he needs.

At their latest paediatric review, Bobby’s parents are given the first glimmers of hope: there is a new test, an exome sequence, that will explore the subtle changes in Bobby’s genes to (hopefully) reveal previously undetected genetic causes for his condition. However, there is a catch — the testing comes in a package where other conditions are also explored at the same time. The parents aren’t interested in anything else and they are confused when the paediatrician tells them Bobby will be tested for a whole set of adult-onset cancers as well as cardiac conditions. The paediatrician explains that these latter conditions are likely to be totally unrelated (‘incidental’) to Bobby’s condition, may not be relevant until Bobby grows up and also it may not be possible to tell with any certainty what the actual risks are of developing them. The parents are surprised — isn’t this a paediatric clinic? Why is a paediatrician talking to them about adult conditions completely outside her area of expertise?

The paediatrician explains that this is just the same as having a full blood count done or an X-ray; there is always the chance of picking up something unexpected. But, the lab will be specifically searching for a set of additional conditions, there doesn’t seem to be much that is ‘incidental’ about this. ‘Call it opportunistic screening’ says the paediatrician’; however, what shocks Bobby’s parents is the fact there is no choice. In order to access the exome sequencing technology they have to receive information on a set list of conditions, there is no opt-out only an opt-in. So, they have to proceed.

Some months later they receive a telephone call from their paediatrician, the exome did not reveal an obvious genetic diagnosis for Bobby’s disabilities however, after several weeks of additional exploratory work by the laboratory staff, they reported a change in a gene called ‘P53’ that is ‘likely’ to given him an increased risk of cancer. The lab had spent a long time looking through the medical literature. Although the gene change looked as if it should be significant in that cancer was possible, the fact that no-one in the family had already had cancer (and the family was large with many people living well into old age), it was difficult to know what this actually meant for Bobby and his parents, and whether cancer screening would be necessary or not. Bobby’s parents are stunned, they proceeded with testing that they had no choice about and now have to deal with uncertain results together with an uncertain plan of action. Should they be worrying about this result or not?  Does it have implications for other members of the family? The paediatrician isn’t sure.